Impact of Real World Evidence Analytics in the New Cancer Drugs Segment

Impact of Real World Evidence Analytics in the New Cancer Drugs Segment

Real world evidence: Is it driving a new archetype in the new cancer drugs segment? The potential for real world evidence is on the rise, especially in the new cancer drugs segment. The appropriate utilization of real world data has the potential to improve the entire drug development process. To withstand the global competitive pressures, […]

READ MORE >>